Transplant Patients

Awareness of periodontal disease by transplant patients.
Solid organ transplantation is one of the most remarkable and dramatic therapeutic advances in medicine during the past 60 years. Nowadays this procedure is considered to be clinically effective, life-saving and cost-effective.

Nevertheless, infection continues to be one of the causes in graft loss or death of transplant recipients. Periodontal disease, a severe dental disorder involving inflammation and infection of the structures that surround and support the teeth, seems to have serious implications in solid-organ transplant deterioration and chronic rejection.

Your health, your safety.
Our team specialists provide a distinctive service to transplant candidates consisting of a comprehensive oral evaluation, which will frequently identify potential sources of infection.

Based in our 10 years of research and experience in diagnosing and treating oral disease in special need patients, we have developed dental protocols designed to ensure that patients listed for solid organ transplant are cleared to undergo surgery.

This consists in a patient specific treatment that will be tailored in close interaction with the referring institution. We strongly believe that these individualised treatment plans should be developed by a multidisciplinary team of transplant surgeons, hepatologists, transplant nurses and dentists.

We are also committed to manage the patients after transplantation, minimizing the risk of unwanted complications or relapses.


There is an increasing burden of Periodontal (gum) disease due to the growing world population associated with an increasing life expectancy.

20% of the world’s adult population are affected by periodontitis.

In the UK the figures are somewhat higher. The NHS estimates that half the adult population has some degree of periodontal disease and most people experience it at least once in their life.

The occurrence of a dental infection prior to transplantation that resulted in a postponement or cancellation was reported by 38% of transplantation centers in the United States.

The results from clinical studies showed that moderate to severe periodontitis was almost universally present in transplant patients.

REFER A PATIENT (All details will be strictly confidential)
  • Referring Practitioner Details

  • Patient Details

  •  /  /
  • Referral Information

  • Should be Empty: